Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1729226

Cover Image

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1729226

Global GCC Animal Health Market Size study, by Product Type, Animal Type (Production Animals, Companion Animals), Distribution Channel, End-use, and Regional Forecasts 2022-2032

PUBLISHED:
PAGES: 285 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4950
Printable PDF (Enterprise License)
USD 6250

Add to Cart

Global GCC Animal Health Market is valued approximately at USD 1.26 billion in 2023 and is projected to grow with a compelling CAGR of 9.45% over the forecast period 2024-2032. As the GCC region accelerates its transformation toward advanced veterinary care and food security initiatives, animal health has emerged as a central pillar in sustainable agriculture, public health, and pet welfare systems. With a dual focus on livestock productivity and companion animal well-being, veterinary pharmaceutical and services stakeholders in GCC countries are embracing high-value solutions-ranging from therapeutics and diagnostics to preventive care and digital health platforms-to address evolving consumer expectations and regulatory frameworks.

The convergence of rising pet adoption, intensified livestock farming practices, and strategic governmental initiatives to curb zoonotic disease outbreaks has significantly catalyzed market demand across the region. Notably, the GCC animal health ecosystem is seeing increased investment in preventive medicines, vaccines, and veterinary diagnostics, driven by growing awareness about disease control, biosecurity measures, and long-term animal wellness. In tandem, technological advances like AI-powered diagnostic tools, tele-veterinary consultation platforms, and RFID-enabled herd monitoring systems are reshaping traditional clinical workflows and enabling real-time animal health tracking in both rural and urban landscapes.

A key accelerant for the market's growth trajectory lies in the seamless collaboration between public veterinary services and private players, including pharmaceutical manufacturers, mobile vet units, and large animal healthcare networks. As companion animal humanization takes deeper root-especially in affluent urban pockets-there's a parallel demand for specialized services such as grooming, dental care, behavioral therapy, and chronic disease management. Simultaneously, producers are seeking access to cost-effective vaccines, nutritional supplements, and animal hygiene solutions that enhance herd resilience, optimize reproduction cycles, and maintain export-compliant safety standards.

From a geographic standpoint, countries such as Saudi Arabia and the United Arab Emirates are spearheading the animal health revolution, with robust veterinary infrastructure, regulatory harmonization with international animal welfare standards, and an expanding base of educated pet owners. Kuwait, Oman, Qatar, and Bahrain are rapidly catching up by leveraging digital vet tech platforms, boosting domestic production of veterinary products, and encouraging the establishment of veterinary colleges and R&D hubs. As a result, the region presents a vibrant, multi-segmented opportunity landscape for both international players and homegrown innovators.

Major market player included in this report are:

  • Elanco Animal Health
  • Boehringer Ingelheim International GmbH
  • Virbac
  • Zoetis Inc.
  • IDEXX Laboratories, Inc.
  • Merck Animal Health
  • Ceva Sante Animale
  • Vetoquinol S.A.
  • Neogen Corporation
  • Phibro Animal Health Corporation
  • Dechra Pharmaceuticals PLC
  • BioVet S.A.
  • Bayer Animal Health
  • Bimeda Holdings PLC
  • Norbrook Laboratories Ltd.

The detailed segments and sub-segment of the market are explained below:

By Product Type

  • Pharmaceuticals
  • Vaccines
  • Feed Additives
  • Diagnostics
  • Others

By Animal Type

  • Production Animals
  • Companion Animals

By Distribution Channel

  • Retail
  • E-Commerce
  • Veterinary Hospitals & Clinics
  • Others

By End-use

  • Veterinary Hospitals & Clinics
  • Homecare Settings
  • Research Institutes & Universities

By Region:

  • Saudi Arabia
  • UAE
  • Qatar
  • Kuwait
  • Oman
  • Bahrain

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with country-level analysis across all GCC countries.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global GCC Animal Health Market Executive Summary

  • 1.1 Market Size & Forecast (2022 - 2032)
  • 1.2 Regional Summary
  • 1.3 Segmental Summary
    • 1.3.1 By Product Type
    • 1.3.2 By Animal Type
    • 1.3.3 By Distribution Channel
    • 1.3.4 By End-use
  • 1.4 Key Trends
  • 1.5 Recession Impact
  • 1.6 Analyst Recommendation & Conclusion

Chapter 2. Global GCC Animal Health Market Definition and Research Assumptions

  • 2.1 Research Objective
  • 2.2 Market Definition
  • 2.3 Research Assumptions
    • 2.3.1 Inclusion & Exclusion
    • 2.3.2 Limitations
    • 2.3.3 Supply Side Analysis
      • 2.3.3.1 Availability
      • 2.3.3.2 Infrastructure
      • 2.3.3.3 Regulatory Environment
      • 2.3.3.4 Market Competition
      • 2.3.3.5 Economic Viability (Consumer's Perspective)
    • 2.3.4 Demand Side Analysis
      • 2.3.4.1 Regulatory Frameworks
      • 2.3.4.2 Technological Advancements
      • 2.3.4.3 Environmental Considerations
      • 2.3.4.4 Consumer Awareness & Acceptance
  • 2.4 Estimation Methodology
  • 2.5 Years Considered for the Study
  • 2.6 Currency Conversion Rates

Chapter 3. Global GCC Animal Health Market Dynamics

  • 3.1 Market Drivers
    • 3.1.1 Rising Pet Adoption and Companion Animal Humanization
    • 3.1.2 Intensified Livestock Farming Practices
    • 3.1.3 Government Initiatives to Curb Zoonotic Disease Outbreaks
    • 3.1.4 Technological Advances in Veterinary Diagnostics and Digital Health
    • 3.1.5 Public-Private Collaboration in Veterinary Services
  • 3.2 Market Challenges
    • 3.2.1 High Cost of Advanced Veterinary Therapies and Vaccines
    • 3.2.2 Regulatory Complexity and Harmonization Across GCC Countries
    • 3.2.3 Supply Chain Disruptions and Logistics Constraints
    • 3.2.4 Shortage of Skilled Veterinary Professionals
    • 3.2.5 Price Sensitivity among Producers and Pet Owners
  • 3.3 Market Opportunities
    • 3.3.1 Growth of Tele-Veterinary Consultation Platforms
    • 3.3.2 Expansion of Domestic Production of Veterinary Products
    • 3.3.3 R&D Hubs and Veterinary Education Initiatives
    • 3.3.4 Adoption of Preventive Medicine and Biosecurity Solutions
    • 3.3.5 Integration of RFID and IoT for Real-Time Herd Monitoring

Chapter 4. Global GCC Animal Health Market Industry Analysis

  • 4.1 Porter's 5 Force Model
    • 4.1.1 Bargaining Power of Suppliers
    • 4.1.2 Bargaining Power of Buyers
    • 4.1.3 Threat of New Entrants
    • 4.1.4 Threat of Substitutes
    • 4.1.5 Competitive Rivalry
    • 4.1.6 Futuristic Approach to Porter's 5 Force Model
    • 4.1.7 Porter's 5 Force Impact Analysis
  • 4.2 PESTEL Analysis
    • 4.2.1 Political
    • 4.2.2 Economical
    • 4.2.3 Social
    • 4.2.4 Technological
    • 4.2.5 Environmental
    • 4.2.6 Legal
  • 4.3 Top Investment Opportunity
  • 4.4 Top Winning Strategies
  • 4.5 Disruptive Trends
  • 4.6 Industry Expert Perspective
  • 4.7 Analyst Recommendation & Conclusion

Chapter 5. Global GCC Animal Health Market Size & Forecasts by Product Type 2022-2032

  • 5.1 Segment Dashboard
  • 5.2 Pharmaceuticals Revenue Trend Analysis, 2022 & 2032
  • 5.3 Vaccines Revenue Trend Analysis, 2022 & 2032
  • 5.4 Feed Additives Revenue Trend Analysis, 2022 & 2032
  • 5.5 Diagnostics Revenue Trend Analysis, 2022 & 2032
  • 5.6 Others Revenue Trend Analysis, 2022 & 2032

Chapter 6. Global GCC Animal Health Market Size & Forecasts by Animal Type 2022-2032

  • 6.1 Segment Dashboard
  • 6.2 Production Animals Revenue Trend Analysis, 2022 & 2032
  • 6.3 Companion Animals Revenue Trend Analysis, 2022 & 2032

Chapter 7. Global GCC Animal Health Market Size & Forecasts by Distribution Channel 2022-2032

  • 7.1 Segment Dashboard
  • 7.2 Retail Revenue Trend Analysis, 2022 & 2032
  • 7.3 E-Commerce Revenue Trend Analysis, 2022 & 2032
  • 7.4 Veterinary Hospitals & Clinics Revenue Trend Analysis, 2022 & 2032
  • 7.5 Others Revenue Trend Analysis, 2022 & 2032

Chapter 8. Global GCC Animal Health Market Size & Forecasts by End-use 2022-2032

  • 8.1 Segment Dashboard
  • 8.2 Veterinary Hospitals & Clinics Revenue Trend Analysis, 2022 & 2032
  • 8.3 Homecare Settings Revenue Trend Analysis, 2022 & 2032
  • 8.4 Research Institutes & Universities Revenue Trend Analysis, 2022 & 2032

Chapter 9. Global GCC Animal Health Market Regional Analysis 2022-2032

  • 9.1 Saudi Arabia
    • 9.1.1 Product Type Breakdown Size & Forecasts, 2022-2032
    • 9.1.2 Animal Type Breakdown Size & Forecasts, 2022-2032
    • 9.1.3 Distribution Channel Breakdown Size & Forecasts, 2022-2032
    • 9.1.4 End-use Breakdown Size & Forecasts, 2022-2032
  • 9.2 United Arab Emirates
    • 9.2.1 Product Type Breakdown...
    • 9.2.2 Animal Type Breakdown...
    • 9.2.3 Distribution Channel Breakdown...
    • 9.2.4 End-use Breakdown...
  • 9.3 Qatar
  • 9.4 Kuwait
  • 9.5 Oman
  • 9.6 Bahrain

Chapter 10. Competitive Intelligence

  • 10.1 Key Company SWOT Analysis
    • 10.1.1 Elanco Animal Health
    • 10.1.2 Boehringer Ingelheim International GmbH
    • 10.1.3 Zoetis Inc.
  • 10.2 Top Market Strategies
  • 10.3 Company Profiles
    • 10.3.1 Elanco Animal Health
      • 10.3.1.1 Key Information
      • 10.3.1.2 Overview
      • 10.3.1.3 Financial (Subject to Data Availability)
      • 10.3.1.4 Product Summary
      • 10.3.1.5 Market Strategies
    • 10.3.2 Boehringer Ingelheim International GmbH
    • 10.3.3 Virbac
    • 10.3.4 IDEXX Laboratories, Inc.
    • 10.3.5 Merck Animal Health
    • 10.3.6 Ceva Sante Animale
    • 10.3.7 Vetoquinol S.A.
    • 10.3.8 Neogen Corporation
    • 10.3.9 Phibro Animal Health Corporation
    • 10.3.10 Dechra Pharmaceuticals PLC
    • 10.3.11 BioVet S.A.
    • 10.3.12 Bayer Animal Health
    • 10.3.13 Bimeda Holdings PLC
    • 10.3.14 Norbrook Laboratories Ltd.

Chapter 11. Research Process

  • 11.1 Research Process
    • 11.1.1 Data Mining
    • 11.1.2 Analysis
    • 11.1.3 Market Estimation
    • 11.1.4 Validation
    • 11.1.5 Publishing
  • 11.2 Research Attributes
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!